Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Insulin-like growth factor 2 reduces Huntington’s disease aggregates via AKT and NF-κB signaling in huntington’s disease

Title: Insulin-like growth factor 2 reduces Huntington’s disease aggregates via AKT and NF-κB signaling in huntington’s disease
Authors: Yun-Shiuan Tung; Chih-Wei Tung; Siew Chin Chan; Yi-Ching Chen; Po-Ming Wu; Pei-Hsun Cheng; Chuan-Mu Chen; Shang-Hsun Yang
Source: Cell & Bioscience, Vol 15, Iss 1, Pp 1-13 (2025)
Publisher Information: BMC
Publication Year: 2025
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: Insulin-like growth factor 2(IGF2); Protein kinase B (AKT); Nuclear factor kappa-light-chain-enhancer of activated B cells(NF-κB); Extracellular vesicles; Mutant Huntingtin; Aggregates; Biotechnology; TP248.13-248.65; Biology (General); QH301-705.5; Biochemistry; QD415-436
Description: Background Aggregation of misfolded mutant Huntingtin (mHTT) is a pathological characteristic in Huntington’s disease (HD), implying clearance of mHTT is a therapeutical direction for this neurodegenerative disorder. Based on previous studies, Insulin-like growth factor 2 (IGF2) enhances microfilament polymerization in HD models; however, the role of IGF2 against mHTT aggregates is still unclear. Results Here, we demonstrate that IGF2 expression is significantly lower in symptomatic HD patients compared to presymptomatic individuals, and IGF2 activation mechanistically enhances phosphorylation of Protein Kinase B(AKT; serine/threonine kinase), which subsequently reduces mHTT aggregates in vitro. Furthermore, IGF2 stimulates Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling, promoting the secretion of mHTT within extracellular vesicles, thereby aiding cellular clearance. In vivo studies in R6/2 HD transgenic mice reveal that IGF2 administration improves motor functions and decreases mHTT levels. Conclusions Collectively, our findings elucidate the multifaceted role of IGF2 in HD, highlighting its therapeutic potential through modulation of AKT and NF-κB signaling pathways.
Document Type: article in journal/newspaper
Language: English
Relation: https://doi.org/10.1186/s13578-025-01452-4; https://doaj.org/toc/2045-3701; https://doaj.org/article/5508015e72bf4f4583b77593840b9fef
DOI: 10.1186/s13578-025-01452-4
Availability: https://doi.org/10.1186/s13578-025-01452-4; https://doaj.org/article/5508015e72bf4f4583b77593840b9fef
Accession Number: edsbas.A54531CB
Database: BASE